Ascelia Pharma Ab Stock Net Asset
| ACE Stock | SEK 3.53 0.18 5.37% |
Ascelia Pharma AB fundamentals help investors to digest information that contributes to Ascelia Pharma's financial success or failures. It also enables traders to predict the movement of Ascelia Stock. The fundamental analysis module provides a way to measure Ascelia Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ascelia Pharma stock.
Ascelia |
Ascelia Pharma AB Company Net Asset Analysis
Ascelia Pharma's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Ascelia Pharma Net Asset | 333.49 M |
Most of Ascelia Pharma's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ascelia Pharma AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Ascelia Pharma AB has a Net Asset of 333.49 M. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The net asset for all Sweden stocks is notably lower than that of the firm.
Ascelia Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ascelia Pharma's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ascelia Pharma could also be used in its relative valuation, which is a method of valuing Ascelia Pharma by comparing valuation metrics of similar companies.Ascelia Pharma is currently under evaluation in net asset category among its peers.
Ascelia Fundamentals
| Return On Equity | -0.54 | |||
| Return On Asset | -0.33 | |||
| Current Valuation | 359.6 M | |||
| Shares Outstanding | 33.67 M | |||
| Shares Owned By Insiders | 22.73 % | |||
| Shares Owned By Institutions | 31.16 % | |||
| Price To Book | 2.34 X | |||
| EBITDA | (129.45 M) | |||
| Net Income | (125.9 M) | |||
| Cash And Equivalents | 219.15 M | |||
| Cash Per Share | 9.69 X | |||
| Total Debt | 553 K | |||
| Current Ratio | 23.69 X | |||
| Book Value Per Share | 5.19 X | |||
| Cash Flow From Operations | (116.56 M) | |||
| Earnings Per Share | (3.67) X | |||
| Target Price | 65.0 | |||
| Number Of Employees | 21 | |||
| Beta | 0.89 | |||
| Market Capitalization | 483.48 M | |||
| Total Asset | 333.49 M | |||
| Net Asset | 333.49 M |
About Ascelia Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ascelia Pharma AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ascelia Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ascelia Pharma AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ascelia Stock Analysis
When running Ascelia Pharma's price analysis, check to measure Ascelia Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascelia Pharma is operating at the current time. Most of Ascelia Pharma's value examination focuses on studying past and present price action to predict the probability of Ascelia Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascelia Pharma's price. Additionally, you may evaluate how the addition of Ascelia Pharma to your portfolios can decrease your overall portfolio volatility.